Prehabilitation with resistance exercise and nutritional support before allogeneic stem cell transplant

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional trial compares an individualized prehabilitation program (resistance training plus nutritional support) added to usual care versus usual care alone for adults awaiting allogeneic hematopoietic stem cell transplantation. The intervention begins at least four weeks before the scheduled transplant and is tailored to each patient's needs and abilities. The primary outcome is health-related quality of life, with secondary outcomes including hospitalization metrics, muscle mass, and muscle function. Patients must be able to perform muscle testing and read Danish or English to participate.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Adult patients \>18 years will be eligible for inclusion if they are scheduled for a allo-HSCT with at least four weeks before their scheduled transplantation date.

Exclusion Criteria:

* pregnancy
* physical or mental disabilities precluding test of muscle function
* inability to read and understand Danish or English

Where it's running

• Copenhagen University Hospital - Rigshospitalet
  Copenhagen, Denmark, Denmark Recruiting

Study contacts

• Study coordinator: Jan Christensen, PhD
• Email: jan.christensen.02@regionh.dk
• Phone: +4522479075

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• VABu Conditioning for elderly AML patients undergoing stem cell transplant

  This trial tests a VABu conditioning regimen to see if it helps older AML patients before allogeneic stem cell transplantation.

  Recruiting Phase 2/3 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07583888

• Donor-derived virus-specific T cell therapy for CMV or adenovirus after organ or stem-cell transplant

  This tests donor-derived virus-specific T cells to treat CMV or adenovirus reactivation in people who have had a solid organ or stem-cell transplant.

  Recruiting Early Phase 1 Ohio State University Comprehensive Cancer Center · Columbus, Ohio and 1 other locations · NCT03665675

• Oral switch for bloodstream infections in immunocompromised children

  This trial tests whether switching from IV to oral antibiotics is just as safe as continuing IV therapy for children with bloodstream infections who are immunocompromised or have a central venous catheter.

  Recruiting at 4 sites Phase 4 Copenhagen University Hospital, Rigshospitalet · Aalborg and 3 other locations · NCT07923266

• Proton Therapy for Mediastinal Lymphoma in Denmark

  This study tests whether using proton therapy for mediastinal lymphoma can lower late-toxicity risk compared with photon therapy in adults.

  Recruiting Copenhagen University Hospital, Rigshospitalet · Copenhagen, Select A State · NCT07817641

• Oral switch for kids with bloodstream infections after starting IV therapy

  This trial will test whether switching from IV to oral antibiotics early is not worse than continuing IV treatment for previously healthy children and teens with uncomplicated bloodstream infections.

  Recruiting at 18 sites Phase 4 Copenhagen University Hospital, Rigshospitalet · Aabenraa and 17 other locations · NCT07791914

• Unilateral vs bilateral lung volume reduction surgery for emphysema

  This trial tests whether operating on one lung or both lungs provides better breathing and quality of life for adults with severe emphysema due to COPD.

  Recruiting Copenhagen University Hospital, Rigshospitalet · Copenhagen · NCT07731958

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.